Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?

More and more clinical trials have explored the role of liquid biopsy in the diagnosis and treatment of EGFR-mutated NSCLC. In certain circumstances, liquid biopsy has unique advantages and offers a new way to detect therapeutic targets, analyze drug resistance mechanisms in advanced patients, and m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical medicine 2023-02, Vol.12 (4), p.1438
Hauptverfasser:	Li, Yi-Ze, Kong, Sheng-Nan, Liu, Yun-Peng, Yang, Yue, Zhang, Hong-Mei
Format:	Artikel
Sprache:	eng
Schlagworte:	Biopsy Cancer Care and treatment Diagnosis DNA methylation Extrachromosomal DNA Gene mutations Genetic aspects Kinases Lung cancer Lung cancer, Non-small cell Medical prognosis Metastasis Methods Mutation Oncology, Experimental Plasma Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!